Statistics for Verona Pharma PLC (id:6440 VRNA)

Valuation metrics

Market cap

2.92B

Enterprise value

23.13B

Trailing P/E (ttm)

-53.96

Forward P/E

-127.36

PEG ratio

-127.36

Price/Sales (ttm)

518.87

Price/Book (mrq)

22.36

Enterprise Value/Revenue

4.11K

Enterprise Value/EBITDA

-153.90

Overview

Shares outstanding

81.83M

Float

392.17M

Shares short

7.52M

% Held by insiders

0.04%

% Held by institutions

0.90%

Average volume (10 days)

1.33M

Average volume (90 days)

Price summary

52-Week low

11.39

52-Week high

40.13

52-Week change

63.84%

Beta

0.42

50-Day moving average

32.77

200-Day moving average

21.59

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

Last split factor

2:1

Last split date

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

September 30th, 2024

Profitability

Profit margin

0.00%

Operating margin

-694.44%

Operational effectiveness

Return on assets

-28.05%

Return on equity

-78.03%

Income statement

Revenue (ttm)

0.07

Revenue per share (ttm)

0.07

Quarterly revenue growth (yoy)

Gross profit (ttm)

0.00

EBITDA

-150,296,992.00

Net income to common (ttm)

-153,723,008.00

Diluted EPS (ttm)

-2.00

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

336.04M

Total cash per share (mrq)

0.51

Total debt (mrq)

122.31M

Total Debt/Equity (mrq)

93.73

Current ratio (mrq)

1.30K%

Book value per share (mrq)

1.60

Cash flow

Cash flow statement

-103,769,000.00

Levered free cash flow (LFCF)

-60,083,000.00